Literature DB >> 16877337

When it comes to blocking lymphatics, it is all a question of time.

M Luisa Iruela-Arispe1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16877337      PMCID： PMC1698778          DOI： 10.2353/ajpath.2006.060427

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  30 in total

1.  An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype.

Authors:  Jeffrey T Wigle; Natasha Harvey; Michael Detmar; Irina Lagutina; Gerard Grosveld; Michael D Gunn; David G Jackson; Guillermo Oliver
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

2.  Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate.

Authors:  Young-Kwon Hong; Natasha Harvey; Yun-Hee Noh; Vivien Schacht; Satoshi Hirakawa; Michael Detmar; Guillermo Oliver
Journal:  Dev Dyn       Date:  2002-11       Impact factor: 3.780

3.  The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man.

Authors:  M E Baldwin; B Catimel; E C Nice; S Roufail; N E Hall; K L Stenvers; M J Karkkainen; K Alitalo; S A Stacker; M G Achen
Journal:  J Biol Chem       Date:  2001-02-20       Impact factor: 5.157

4.  The lymphatic continuum: the past, present, and exciting future of lymphatic research.

Authors:  Stanley G Rockson
Journal:  Ann N Y Acad Sci       Date:  2002-12       Impact factor: 5.691

5.  Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.

Authors:  Terhi Karpanen; Maria Wirzenius; Taija Mäkinen; Tanja Veikkola; Hidde J Haisma; Marc G Achen; Steven A Stacker; Bronislaw Pytowski; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

6.  Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase.

Authors:  A Irrthum; M J Karkkainen; K Devriendt; K Alitalo; M Vikkula
Journal:  Am J Hum Genet       Date:  2000-06-09       Impact factor: 11.025

7.  Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers.

Authors:  S A Stacker; K Stenvers; C Caesar; A Vitali; T Domagala; E Nice; S Roufail; R J Simpson; R Moritz; T Karpanen; K Alitalo; M G Achen
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

8.  Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations.

Authors:  S E Hong; Y Y Shugart; D T Huang; S A Shahwan; P E Grant; J O Hourihane; N D Martin; C A Walsh
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

9.  VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.

Authors:  S A Stacker; C Caesar; M E Baldwin; G E Thornton; R A Williams; R Prevo; D G Jackson; S Nishikawa; H Kubo; M G Achen
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

10.  Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia.

Authors:  Alexandre Irrthum; Koenraad Devriendt; David Chitayat; Gert Matthijs; Conrad Glade; Peter M Steijlen; Jean-Pierre Fryns; Maurice A M Van Steensel; Miikka Vikkula
Journal:  Am J Hum Genet       Date:  2003-05-08       Impact factor: 11.025
View more
  1 in total

1.  Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice.

Authors:  Jianxin Fu; Holger Gerhardt; J Michael McDaniel; Baoyun Xia; Xiaowei Liu; Lacramioara Ivanciu; Annelii Ny; Karlien Hermans; Robert Silasi-Mansat; Samuel McGee; Emma Nye; Tongzhong Ju; Maria I Ramirez; Peter Carmeliet; Richard D Cummings; Florea Lupu; Lijun Xia
Journal:  J Clin Invest       Date:  2008-10-16       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.